1-9 of 9
Yan Peng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO5-26-02: Changes in Breast Cancer Optoacoustic Imaging Features During Neoadjuvant Therapy and Correlation with Pathologic Response: A feasibility study

Free
Baṣak Dogan, Berat Bersu Ozcan, Heather McArthur, Yan Peng
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO5-26-02.
https://doi.org/10.1158/1538-7445.SABCS23-PO5-26-02
Published: 02 May 2024
View articletitled, Abstract PO5-26-02: Changes in Breast Cancer Optoacoustic Imaging Features During Neoadjuvant Therapy and Correlation with Pathologic Response: A feasibility study
Journal Articles

Abstract PO3-24-02: Molecular characterization and therapeutic approach for VISTA+ triple-negative breast cancers

Free
Yan Zhao, Fatima Charles, Andrew Lipchik, Yan Peng, James Ford, Melinda Telli, Song Zhang, Allison Kurian, Michael Snyder, Joshua Gruber
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO3-24-02.
https://doi.org/10.1158/1538-7445.SABCS23-PO3-24-02
Published: 02 May 2024
View articletitled, Abstract PO3-24-02: Molecular characterization and therapeutic approach for VISTA+ triple-negative breast cancers
Journal Articles

AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer

Free
Mauricio Marquez-Palencia, Luis Reza Herrera, Pravat Kumar Parida, Suvranil Ghosh, Kangsan Kim, Nikitha M. Das, Paula I. Gonzalez-Ericsson, Melinda E. Sanders, Bret C. Mobley, Sebastian Diegeler, Todd A. Aguilera, Yan Peng, Cheryl M. Lewis, Carlos L. Arteaga, Ariella B. Hanker, Angelique W. Whitehurst, James B. Lorens, Rolf A. Brekken, Anthony J. Davis, Srinivas Malladi
Journal: Cancer Research
Cancer Res (2024) 84 (5): 675–687.
https://doi.org/10.1158/0008-5472.CAN-23-1459
Published: 04 March 2024
View articletitled, AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer
Open the PDF for AXL/WRNIP1 Mediates Replication Stress Response and Promotes Therapy Resistance and Metachronous Metastasis in HER2+ Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract B027: Molecular characterization and therapeutic approaches for VISTA+ triple-negative breast cancers

Free
Joshua Gruber, Yan Zhao, Fatima Charles, Priyanka Reddy, Kristina Paul, Virginia Ezenwa, Marisa Juntilla, Idit Sagiv-Barfi, Yan Peng, Song Zhang, Allison Kurian, Michael Snyder
Journal: Cancer Research
Cancer Res (2024) 84 (3_Supplement_1): B027.
https://doi.org/10.1158/1538-7445.ADVBC23-B027
Published: 01 February 2024
View articletitled, Abstract B027: Molecular characterization and therapeutic approaches for VISTA+ triple-negative breast cancers
Journal Articles

Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer

Free
Chengheng Liao, Wentong Fang, Rachel Shi, Jeremy Simon, Travis Ptacek, Giada Zurlo, Youqiong Ye, Leng Han, Cheng Fan, Lei Bao, Christopher Llynard Ortiz, Hong-Rui Lin, Ujjawal Manocha, Weibo Luo, Yan Peng, William Y Kim, Lee-Wei Yang, Qing Zhang
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): P4-08-23.
https://doi.org/10.1158/1538-7445.SABCS22-P4-08-23
Published: 01 March 2023
View articletitled, Abstract P4-08-23: ZHX2 promotes HIF1α oncogenic signaling in triple-negative breast cancer
Journal Articles

Abstract P1-02-14: A comparative analysis of clinical and pathologic characteristics of patients with HER2 positive breast cancer treated with neoadjuvant versus adjuvant anti-HER2 therapy: Analysis of 397 cases

Free
Venetia Sarode, Tricia Rood, Yulun Liu, Yisheng Fang, Sunati Sahoo, Yan Peng, Helena Hwang, Marilyn Leitch, Barbara Haley
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P1-02-14.
https://doi.org/10.1158/1538-7445.SABCS21-P1-02-14
Published: 15 February 2022
View articletitled, Abstract P1-02-14: A comparative analysis of clinical and pathologic characteristics of patients with HER2 positive breast cancer treated with neoadjuvant versus adjuvant anti-HER2 therapy: Analysis of 397 cases
Journal Articles

Abstract PD15-10: Identification of BBOX1 as a therapeutic target in triple-negative breast cancer

Free
Chengheng Liao, Yang Zhang, Cheng Fan, Laura E. Herring, Juan Liu, Jason W. Locasale, Mamoru Takada, Jin Zhou, Giada Zurlo, Lianxin Hu, Jeremy M. Simon, Travis S. Ptacek, Victor G. Andrianov, Einars Loza, Yan Peng, Huanghe Yang, Charles M. Perou, Qing Zhang
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD15-10.
https://doi.org/10.1158/1538-7445.SABCS20-PD15-10
Published: 15 February 2021
View articletitled, Abstract PD15-10: Identification of BBOX1 as a therapeutic target in triple-negative breast cancer
Journal Articles

Abstract 82: Epigenetic reader ZMYND8 bridges BRD4 and hypoxia-inducible factors to mediate breast cancer progression and metastasis

Free
Yan Chen, Bo Zhang, Lei Bao, Lai Jin, Mingming Yang, Yan Peng, Jennifer Wang, Chenliang Wang, Xuan Zou, Yingfei Wang, Weibo Luo
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 82.
https://doi.org/10.1158/1538-7445.AM2018-82
Published: 01 July 2018
View articletitled, Abstract 82: Epigenetic reader ZMYND8 bridges BRD4 and hypoxia-inducible factors to mediate breast cancer progression and metastasis
Journal Articles

The Use of the l-Plastin Promoter for Adenoviral-mediated, Tumor-specific Gene Expression in Ovarian and Bladder Cancer Cell Lines1

Free
Xue Yan Peng, Jong Ho Won, Thomas Rutherford, Takuma Fujii, Daniel Zelterman, Giuseppi Pizzorno, Eva Sapi, John Leavitt, Barry Kacinski, Ronald Crystal, Peter Schwartz, Albert Deisseroth
Journal: Cancer Research
Cancer Res (2001) 61 (11): 4405–4413.
Published: 01 June 2001
View articletitled, The Use of the l-Plastin Promoter for Adenoviral-mediated, Tumor-specific Gene Expression in Ovarian and Bladder Cancer Cell Lines1
Open the PDF for The Use of the l-Plastin Promoter for Adenoviral-mediated, Tumor-specific Gene Expression in Ovarian and Bladder Cancer Cell Lines1 in another window